• Main
  • Boost for Drug Development Institute

    The Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs Expanded
    25 July 2018
    From left: Prof. Prof. Danny Chamovitz, Dean Life Sciences; Mrs. Marina Prajs; Uwe Becker, President German Friends Association; Dr. Mira Marcus-Kalish, Director International Research Affairs; Mrs. Norma Drimmer; Prof. Yoav Henis, TAU Vice President R&D; Prof. Ronit Pinkas-Kramarski, Director of the Prajs-Drimmer Institute; Mr. Neil Fishler; Dr. h.c. Sruel Prajs; Mr. David Prajs; Prof. Karen Avraham, Vice Dean Sackler Medical Faculty.

    A plaque unveiling ceremony was held on campus to celebrate additional support of the Prajs and Drimmer families for the Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs at the George S. Wise Faculty of Life Sciences. The additional funding supports extended research, fellowships and multidisciplinary collaboration between young scientists in the Faculties of Life Sciences and Medicine.

     

    The ceremony was held in the presence of Norma Drimmer and her brother, TAU Honorary Doctor Sruel Prajs from Berlin, who founded the Institute in 2008. In his opening greetings, Dean of Life Sciences Prof. Danny Chamovitz thanked Sruel Prajs and Norma Drimmer for their longstanding support to young researchers.

     

    President of the German Friends Association and Mayor of Frankfurt a.M. Uwe Becker stressed the vast philanthropic activity of both Sruel Prajs and Norma Drimmer throughout their lives, and their continued support for Israel, for Jewish causes and of Tel Aviv University. 

     

    The donors thanked the audience for their attendance and emphasized how important it was for them to support research and young scientists in such important fields of research. Together with Vice President for R&D Prof. Yoav Henis, they presented fellowships and travel grants to students.

     

    Prof. Ronit Pinkas-Kramarski, Director of the Institute and Chair of the Department of Neurobiology, spoke on identifying new targets for cancer therapy, while Dr. Eran Schmukler lectured on the identification of novel targets for treating neurodegenerative diseases.

     

    Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
    UI/UX Basch_Interactive